Progress, challenges and global approaches to rare diseases-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Progress, challenges and global approaches to rare diseases

Published:2021-06-19 Issue:10 Volume:110 Page:2711-2716
ISSN:0803-5253
Container-title:Acta Paediatrica
language:en
Short-container-title:Acta Paediatr

Author:

Groft Stephen C.¹^ORCID,Posada Manuel²,Taruscio Domenica³

Affiliation:

1. National Center for Advancing Translational Sciences National Institutes of Health Bethesda MD USA

2. Institute of Rare Diseases Research (IIER) Instituto de Salud Carlos III Madrid Spain

3. National Centre for Rare Diseases Istituto Superiore di Sanità Rome Italy

Publisher

Wiley

Subject

General Medicine,Pediatrics, Perinatology, and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/apa.15974

Reference32 articles.

1. International Collaboration on Rare Diseases and Orphan Drugs (ICORD). Accessed May 26 2021 Available from:http://www.icord.es/

2. Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database

3. The burden of rare diseases

4. Global Genes.RARE Facts. Accessed May 26 2021. Available from:https://globalgenes.org/rare‐facts/

5. Orphan Drug Act Public Law 97‐414 USA. Accessed May 26 2021. Available from:https://uscode.house.gov/statutes/pl/97/414.pdf

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Parent‐reported outcome measures evaluating communication in individuals with rare neurodevelopmental disorders: A systematic review;International Journal of Language & Communication Disorders;2024-08-14

2. Navigating the Unique Challenges of Caregiving for Children with Rare Diseases: Are the Care Experiences of All Caregivers the Same? A Focus on Life-Limiting Rare Diseases;Journal of Clinical Medicine;2024-08-01

3. Increasing Diversity, Equity, Inclusion, and Accessibility in Rare Disease Clinical Trials;Pharmaceutical Medicine;2024-07

4. Rare disease publishing trends worldwide and in China: a citespace-based bibliometric study;2024-06-28

5. Towards a standard benchmark for variant and gene prioritisation algorithms: PhEval - Phenotypic inference Evaluation framework;2024-06-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3